Table 1.
Variables | Value |
---|---|
Age, years; mean (range) |
57 (29 to 82) |
Gender, n (%) |
|
Male |
31 (56.4) |
Female |
24 (23.6) |
Malignancy, n (%) |
|
Lung cancer |
36 (65.5) |
Hematologic malignancy |
4 |
GI cancer |
5 |
Breast cancer |
6 |
Ovary cancer |
1 |
Thyroid cancer |
1 |
Cardiac sarcoma |
1 |
Thymoma |
1 |
Time to PE after cancer diagnosis. months |
9 (0 to 180) |
Dyspnea, n (%) |
45 (81.8) |
Electrocardiography, n (%) |
|
Normal |
23 (41.8) |
Abnormal |
32 (58.2) |
Sinus tachycardia |
20 |
Low voltage |
9 |
Atrial fibrillation |
2 |
APC |
1 |
Cardiac tamponade, n (%) |
28 (50.9) |
Ejection fraction, (%) |
62% (48 to 75) |
Prior pericardiocentesis, n (%) |
15 (27.3) |
Recurrence after pericardiocentesis, n |
8 |
Maximum distance of pericardial space by CT, mm |
32.25 (11.7 to 54.68) |
Concomitant pleural effusion, n (%) |
39 (70.9) |
Mediastinal lymphadenopathy, n (%) |
40 (72.7) |
Prior radiotherapy of the chest, n (%) |
22 (40) |
Pericardial metastasis by CT, n (%) |
20 (36.4) |
Pulmonary thromboembolism, n (%) |
3 (5.5) |
Extrathoracic metastasis, n (%) | 32 (58.2) |
APC, Atrial premature contraction; CT, Computed tomography; GI, Gastrointestinal; PE, Pericardial effusion.
aData are presented as median (range) unless otherwise stated.